Physician profile
Michael J Samaan
NPI 1659368652
$678.79
in general payments reported to CMS, 2019-2025
18 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.15 · 2021: $21.98 · 2022: $64.60 · 2023: $154 · 2024: $138 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $153.25 | 2023-2025 | Epclusa |
| Baxter Healthcare | $61.49 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Abbvie INC. | $61.03 | 2023-2025 | Vraylar |
| Axsome Therapeutics, INC. | $60.93 | 2025 | Auvelity |
| Pfizer INC. | $49.42 | 2022 | |
| Glaxosmithkline, LLC. | $41.98 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $38.80 | 2024 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $34.94 | 2025 | Rexulti |
| Daiichi Sankyo INC. | $26.52 | 2023 | Injectafer |
| Inari Medical, INC. | $21.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $20.70 | 2025 | Gardasil 9, Capvaxive, Enflonsia |
| Lilly USA, LLC | $19.17 | 2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $18.68 | 2023 | Trintellix |
| Braeburn INC. | $18.50 | 2024 | Brixadi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.88 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.69 | 2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $13.03 | 2023 | Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $7.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Samaan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.